These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 9468019)

  • 21. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
    Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary adenylate cyclase-activating polypeptide regulates rat Leydig cell function in vitro.
    Romanelli F; Fillo S; Isidori A; Conte D
    Neuropeptides; 1997 Aug; 31(4):311-7. PubMed ID: 9308016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors.
    Juarranz MG; Bolaños O; Gutiérrez-Cañas I; Lerner EA; Robberecht P; Carmena MJ; Prieto JC; Rodríguez-Henche N
    Cell Signal; 2001 Dec; 13(12):887-94. PubMed ID: 11728828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes.
    Gräs S; Hedetoft C; Pedersen SH; Fahrenkrug J
    Biol Reprod; 2000 Jul; 63(1):206-12. PubMed ID: 10859261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors and PACAP in human fetal retina.
    Olianas MC; Ingianni A; Sogos V; Onali P
    J Neurochem; 1997 Sep; 69(3):1213-8. PubMed ID: 9282945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
    Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
    Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) potentiate the glutamate-evoked release of arachidonic acid from mouse cortical neurons. Evidence for a cAMP-independent mechanism.
    Stella N; Magistretti PJ
    J Biol Chem; 1996 Sep; 271(39):23705-10. PubMed ID: 8798593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat aortic smooth-muscle cell proliferation is bidirectionally regulated in a cell cycle-dependent manner via PACAP/VIP type 2 receptor.
    Miyata A; Sato K; Hino J; Tamakawa H; Matsuo H; Kangawa K
    Ann N Y Acad Sci; 1998 Dec; 865():73-81. PubMed ID: 9927999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor.
    Sano H; Miyata A; Horio T; Nishikimi T; Matsuo H; Kangawa K
    Regul Pept; 2002 Nov; 109(1-3):107-13. PubMed ID: 12409222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion.
    Inagaki N; Kuromi H; Seino S
    Ann N Y Acad Sci; 1996 Dec; 805():44-51; discussion 52-3. PubMed ID: 8993392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways.
    Braas KM; May V
    J Biol Chem; 1999 Sep; 274(39):27702-10. PubMed ID: 10488112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Switches in the expression and function of PACAP and VIP receptors during phenotypic interconversion in human neuroblastoma cells.
    Lelièvre V; Becq-Giraudon L; Meunier AC; Muller JM
    Neuropeptides; 1996 Aug; 30(4):313-22. PubMed ID: 8914856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle.
    Ekblad E; Sundler F
    Eur J Pharmacol; 1997 Sep; 334(1):61-6. PubMed ID: 9346329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes.
    Grimaldi M; Cavallaro S
    Eur J Neurosci; 1999 Aug; 11(8):2767-72. PubMed ID: 10457173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.
    Kim WK; Kan Y; Ganea D; Hart RP; Gozes I; Jonakait GM
    J Neurosci; 2000 May; 20(10):3622-30. PubMed ID: 10804204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Busto R; Sánchez-Chapado M; Guijarro LG; Prieto JC
    Cell Signal; 1999 Nov; 11(11):813-9. PubMed ID: 10617284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous activation of pituitary adenylate cyclase-activating polypeptide receptors elicits antipodal effects on cyclic AMP and inositol phospholipid signaling pathways in CATH.a cells: role of protein synthesis and protein kinases.
    Muller A; Lutz-Bucher B; Kienlen-Campard P; Koch B; Loeffler JP
    J Neurochem; 1998 Apr; 70(4):1431-40. PubMed ID: 9523559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.